CDK4 and neoplasm: In patients who are potential candidates for CDK4/6 inhibitors and are cN0 with a higher ratio of tumor dimension to Ki67 proliferation index, intraoperative evaluation of SNLB should be performed in order to avoid secondary surgery and reduce the time between surgery and the initiation of adjuvant treatment.